REGEN BIOPHARMA, INC.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-1.1M | $-1.1M | — | — |
| FY2022 | $-606.9K | $-606.9K | — | — |
| FY2023 | $-173.9K | $-173.9K | — | $348.4K |
| FY2024 | $-751.5K | $-751.5K | — | $13.0K |
| FY2025 | $-383.6K | $-383.6K | — | — |